Yandong Li

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Ischemia Reperfusion Injury

Cell Proliferation

Top Venues

Cancer gene therapy

Cell death & disease

Journal of cellular and molecular medicine

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Jiahua Yu, Shijun Yu, Jin Bai, Zhe Zhu, Yong Gao, Yandong Li
SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer. Cancer gene therapy 31 (5) (2024)
Jiahua Yu, Shijun Yu, Jin Bai, Zhe Zhu, Yong Gao, Yandong Li
SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer. Cancer gene therapy (2024)
Jiahua Yu, Shijun Yu, Jin Bai, Zhe Zhu, Yong Gao, Yandong Li
SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer. Cancer gene therapy 31 (5) (2024)
Xuedi Gao, Wenfang Bao, Jin Bai, Kailing Fan, Li Li, Yandong Li
UHMK1 aids colorectal cancer cell proliferation and chemoresistance through augmenting IL-6/STAT3 signaling. Cell death & disease 13 (5) (2022)
Li Li, Shijun Yu, Jingde Chen, Ming Quan, Yong Gao, Yandong Li
miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation. Cell death discovery 8 (1) (2022)
Mengxi Xiu, Li Li, Yandong Li, Yong Gao
An update regarding the role of WNK kinases in cancer. Cell death & disease 13 (9) (2022)
Shijun Yu, Jingde Chen, Ming Quan, Li Li, Yandong Li, Yong Gao
CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine-induced STAT3 activation. Journal of cellular and molecular medicine 25 (2) (2020)